Icariin ameliorates streptozotocin-induced diabetic retinopathy in Vitro and in Vivo

International Journal of Molecular Sciences

Volumn 13, Issue 1, 2012, Pages 866-878

  Xin, Hua ^a   Zhou, Feng ^b   Liu, Tao ^b   Li, Guang Yong ^b   Liu, Jing ^b   Gao, Zhe Zhu ^b   Bai, Guang Yi ^b   Lu, Hong ^a   Xin, Zhong Cheng ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Diabetes; Diabetic retinopathy; Icariin; Retina; Streptozotocin

Indexed keywords

COLLAGEN TYPE 4; GLUCOSE; ICARIIN; PLACEBO; RECA PROTEIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR POU4F1; VASCULOTROPIN; FLAVONOID; STREPTOZOCIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIET SUPPLEMENTATION; DOWN REGULATION; DRUG TARGETING; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; MALE; MUELLER CELL; NERVE FIBER GROWTH; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RETINA GANGLION CELL; SHAM PROCEDURE; STREPTOZOCIN DIABETES; TREATMENT DURATION; UPREGULATION; ANIMAL; CHEMICALLY INDUCED; CYTOLOGY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; METABOLISM; PATHOLOGY; RETINA; RETINA BLOOD VESSEL; SPRAGUE DAWLEY RAT; TOXICITY;

ANIMALIA; RATTUS;

ANIMALS; ANTIGENS, THY-1; COLLAGEN TYPE IV; DIABETES MELLITUS, EXPERIMENTAL; FLAVONOIDS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REC A RECOMBINASES; RETINA; RETINAL GANGLION CELLS; RETINAL VESSELS; STREPTOZOCIN; TRANSCRIPTION FACTOR BRN-3A; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863074195     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13010866     Document Type: Article

References (31)

1. Congdon, N.; O'Colmain, B.; Klaver, C.C.; Klein, R.; Muñoz, B.; Friedman, D.S.; Kempen, J.; Taylor, H.R.; Mitchell, P. Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 2004, 122, 477-485.
2. Marshall, S.M.; Flyvbjerg, A. Prevention and early detection of vascular complications of diabetes. Br. Med. J. 2006, 333, 475-480.
3. Klein, R.; Klein, B.E.; Moss, S.E. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992, 15, 1875-1891.
4. Frank, R.N. Diabetic retinopathy. N. Engl. J. Med. 2004, 350, 48-58.
5. Curtis, T.M.; Gardiner, T.A.; Stitt, A.W. Microvascular lesions of diabetic retinopathy: Clues towards understanding pathogenesis? Eye (Lond.) 2009, 23, 1496-1508.
6. de la Cruz, J.P.; Gonzalez-Correa, J.A.; Guerrero, A.; de la Cuesta, F.S. Pharmacological approach to diabetic retinopathy. Diabetes Metab. Res. Rev. 2004, 20, 91-113.
7. Antonetti, D.A.; Barber, A.J.; Bronson, S.K.; Freeman, W.M.; Gardner, T.W.; Jefferson, L.S.; Kester, M.; Kimball, S.R.; Krady, J.K.; LaNoue, K.F.; et al. JDRF Diabetic Retinopathy Center Group. Diabetic retinopathy: Seeing beyond glucose-induced microvascular disease. Diabetes 2006, 55, 2401-2411.
8. Xin, Z.C.; Kim, E.K.; Lin, C.S.; Liu, W.J.; Tian, L.; Yuan, Y.M.; Fu, J. Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities. Asian J. Androl. 2003, 5, 15-18.
9. Wang, H.; Liu, Y.; Huai, Q.; Cai, J.; Zoraghi, R.; Francis, S.H.; Corbin, J.D.; Robinson, H.; Xin, Z.; Lin, G.; Ke, H. Multiple conformations of phosphodiesterase-5: Implications for enzyme function and drug development. J. Biol. Chem. 2006, 281, 21469-21479.
10. Liu, W.J.; Xin, Z.C.; Xin, H.; Yuan, Y.M.; Tian, L.; Guo, Y.L. Effects of icariin on erectile function and expression of nitric oxide synthase isoforms in castrated rats. Asian J. Androl. 2005, 7, 381-388.
11. Shindel, A.W.; Xin, Z.C.; Lin, G.; Fandel, T.M.; Huang, Y.C.; Banie, L.; Breyer, B.N.; Garcia, M.M.; Lin, C.S.; Lue, T.F. Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo. J. Sex. Med. 2010, 7, 1518-1528.
12. Liu, T.; Xin, H.; Li, W.R.; Zhou, F.; Li, G.Y.; Gong, Y.Q.; Gao, Z.Z.; Qin, X.C.; Cui, W.S.; Shindel, A.W.; Xin, Z.C. Effects of icariin on improving erectile function in streptozotocin-induced diabetic rats. J. Sex. Med. 2011, 8, 2761-2772.
13. Qi, M.Y.; Kai, C.; Liu, H.R.; Su, Y.H.; Yu, S.Q. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor beta(1) and type IV collagen expression in rats. J. Ethnopharmacol. 2011, 138, 731-736.
14. Reichenbach, A.; Wurm, A.; Pannicke, T.; Iandiev, I.; Wiedemann, P.; Bringmann, A. Muller cells as players in retinal degeneration and edema. Graefes Arch. Clin. Exp. Ophthalmol. 2007, 245, 627-636.
15. Pambianco, G.; Costacou, T.; Ellis, D.; Becker, D.J.; Klein, R.; Orchard, T.J. The 30-year natural history of type 1 diabetes complications-The Pittsburgh epidemiology of diabetes complications study experience. Diabetes 2006, 55, 1463-1469.
16. Zhang, W.; Liu, H.; Al-Shabrawey, M.; Caldwell, R.W.; Caldwell, R.B. Inflammation and diabetic retinal microvascular complications. J. Cardiovasc. Dis. Res. 2011, 2, 96-103.
17. Zong, H.; Ward, M.; Stitt, A.W. AGEs, RAGE, and diabetic retinopathy. Curr. Diabetes Rep. 2011, 11, 244-252.
18. Edwards, P.J.; Barnard, L.; Leonard, V.K.; Yi, J.S.; Moloney, K.P.; Kongnakorn, T.; Jacko, J.A.; Sainfort, F. Understanding users with diabetic retinopathy: Factors that affect performance in a menu selection task. Behav. Inf. Technol. 2005, 24, 175-186.
19. Shahidi, A.M.; Sampson, G.P.; Pritchard, N.; Edwards, K.; Russell, A.; Malik, R.A.; Efron, N. Exploring retinal and functional markers of diabetic neuropathy. Clin. Exp. Optom. 2010, 93, 309-323.
20. Chrissobolis, S.; Miller, A.A.; Drummond, G.R.; Kemp-Harper, B.K.; Sobey, C.G. Oxidative stress and endothelial dysfunction in cerebrovascular disease. Front. Biosci. 2011, 16, 1733-1745.
21. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414, 813-820.
22. Ceriello, A. Hypothesis: The "metabolic memory", the new challenge of diabetes. Diabetes Res. Clin. Pract. 2009, 86, S2-S6.
23. Li, Q.; Ao, X.; Du, Y.; Li, Y.; Ou, Y.; Gong, R.; Sun, X.; Yang, Y.X.; Wen, G. Effects of aminoguanidine and vitamin C on collagen type IV in diabetic nephropathy rats. Endocrine 2011, 39, 251-258.
24. Jonas, J.B. Clinical implications of peripapillary atrophy in glaucoma. Curr. Opin. Ophthalmol. 2005, 16, 84-88.
25. Usta, M.F.; Kendirci, M.; Gur, S.; Foxwell, N.A.; Bivalacqua, T.J.; Cellek, S.; Hellstrom, W.J. The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: Preventive versus curative treatment. J. Sex. Med. 2006, 3, 242-252.
26. Chen, Y.; Yang, R.; Yao, L.; Sun, Z.; Wang, R.; Dai, Y. Differential expression of neurotrophins in penises of streptozotocin-induced diabetic rats. J. Androl. 2007, 28, 306-312.
27. Li, J.; Wang, J.J.; Yu, Q.; Chen, K.; Mahadev, K.; Zhang, S.X. Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: Role of NADPH oxidase 4. Diabetes 2010, 59, 1528-1538.
28. Sivakumar, V.; Zhang, Y.; Ling, E.A.; Foulds, W.S.; Kaur, C. Insulin-like growth factors, angiopoietin-2, and pigment epithelium-derived growth factor in the hypoxic retina. J. Neurosci. Res. 2008, 86, 702-711.
29. Sanchez-Migallon, M.C.; Nadal-Nicolas, F.M.; Jimenez-Lopez, M.; Sobrado-Calvo, P.; Vidal-Sanz, M.; Agudo-Barriuso, M. Brain derived neurotrophic factor maintains Brn3a expression in axotomized rat retinal ganglion cells. Exp. Eye Res. 2011, 92, 260-267.
30. Zhang, X.M.; Li Liu, D.T.; Chiang, S.W.; Choy, K.W.; Pang, C.P.; Lam, D.S.; Yam, G.H. Immunopanning purification and long-term culture of human retinal ganglion cells. Mol. Vis. 2010, 16, 2867-2872.
31. Bian, Z.M.; Elner, S.G.; Elner, V.M. Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells. Exp. Eye Res. 2007, 84, 812-822.